In the realm of pharmaceutical research, Caco-2 cells have long been heralded as the gold standard for studying intestinal absorption and
Meet the CN Bio team – Oliver Culley
Welcome back to our “Meet the CN Bio team” blog series, where we are showcasing the unique expertise and talent that makes us who we are. We caught
CN Bio launches PhysioMimix Bioavailability assay kit: Human 18
Unique solution enabling researchers to profile human oral drug bioavailability in vitro, in their own laboratories Cambridge, UK, 14 November
User Group Meeting 2024 – Recap
Meet the CN Bio team – Uranbileg Myagmarsuren
Welcome back to our “Meet the CN Bio team” blog series, where we are showcasing the unique expertise and talent that makes us who we are. We sat
6 Challenges in ADME Drug Development
When developing drugs, we rely heavily on in vitro, in vivo animal and in silico models to predict how the human body will interact with drugs before
Meet the CN Bio team – Joanna Michalowska
Welcome to our new "Meet the CN Bio team" blog series, where you'll get a behind-the-scenes look at the incredible individuals who make our company
How in vitro human Gut/Liver models increase confidence in ADME estimations before human trials
Imagine a world where developing new medicines is faster, cheaper, and less reliant on the use of animals for testing. Novel multi-organ in vitro
Organ-on-a-chip adoption: The roadmap to broader use
Paving the way for Organ-on-a-chip adoption Drug discovery is becoming more complex as we move from a small molecule world to large molecules and